Table 4 Multivariate analysis: predicting all cause and cardiovascular disease mortality
Number of person time intervals, nAll cause mortality, adjusted OR (95% CI)CVD mortality, adjusted OR (95% CI)
Baseline NSAIDAll IP56340.62 (0.45 to 0.84)0.54 (0.34 to 0.86)
RA37910.65 (0.45 to 0.93)0.69 (0.39 to 1.20)
Ever NSAIDAll IP56340.52 (0.36 to 0.76)0.38 (0.23 to 0.66)
RA37910.61 (0.38 to 0.98)0.53 (0.27 to 1.06)
Time-varying NSAID useAll IP56340.72 (0.52 to 1.00)0.66 (0.40 to 1.09)
RA37910.75 (0.52 to 1.08)0.86 (0.49 to 1.49)
  • RA status refers to cumulative RA status by the sixth assessment. Final multivariate model adjusted for time-varying age, gender, RF, RA status, nodules, tertiles of swollen and tender joint counts, CRP, HAQ, number of medications other than arthritis medication, number of CVD medications, corticosteroid use, methotrexate use and other DMARD use, smoking history

  • CRP, C-reactive protein; CVD, cardiovascular disease; DMARD, disease-modiftying antirheumatic drug; HAQ, Health Assessment Questionnaire; NSAID, non-steroidal anti-inflammatory drug; OR, odds ratio; IP, inflammatory polyarthritis; RA, rheumatoid arthritis; RF, rheumatoid factor.